Showing 431-440 of 856 results for "".
- ASDSA Applauds FDA for Safety Communication on Needle-less Injector Deviceshttps://modernaesthetics.com/news/asdsa-applauds-fda-for-safety-communication-on-needle-less-injector-devices/2473151/The American Society for Dermatologic Surgery Association (ASDSA) applauds the U.S. Food and Drug Administration (FDA) for sending out a safety communication regarding needle-less devices, such as hyaluron p
- Aesthetics Biomedical, US Dermatology Partners Enter Long-term Partnershiphttps://modernaesthetics.com/news/aesthetics-biomedical-us-dermatology-partners-enter-long-term-partnership/2473150/Aesthetics Biomedical® Inc. is entering a long-term partnership with U.S. Dermatology Partners, the largest physician-led dermatology practice in the US, to bring Vivace procedures and ther
- Elite World Group Taps Elysium Health to Develop Science-First Skincare Linehttps://modernaesthetics.com/news/elite-world-group-taps-leading-elysium-health-to-develop-science-first-skincare-line/2473133/Elysium Health, Inc. is joining forces with Elite World Group to develop a line of skincare products. Launching in spring 2022, the line is currently in development and will be sold under an independent trademark. Elite World Group's talent media network, paired wit
- Allergan to Buy Soliton and Resonic, Its Rapid Acoustic Pulse Devicehttps://modernaesthetics.com/news/allergan-to-buy-soliton/2473103/Allergan Aesthetics is set to acquire Soliton and Resonic, its Rapid Acoustic Pulse device. Resonic recently received U.S. Food and Drug Administration (FDA) 510(k) clearance and is a non-invasive treatment for the short-term improvement in the appearance of cellulite. The acquisition o
- Dr. Deanne Mraz Robinson is Now CMO at Ideal Imagehttps://modernaesthetics.com/news/dr-deanne-mraz-robinson-is-now-cmo-at-ideal-image/2473099/Deanne Mraz Robinson, MD, FAAD has been appointed to serve as Chief Medical Officer for Ideal Image. She will be responsible for the overall direction of treatments and services offered by Ideal Image, the education of its clinical specialists, and he
- Dermatologists Report Uptick in Cosmetic Consults Due to Zoom Dysmorphiahttps://modernaesthetics.com/news/dermatologists-report-uptick-in-cosmetic-consults-due-to-zoom-dysmorphia/2473093/During the pandemic, there was a shift to remote work, and demand for video conferencing increased which sired a corresponding rise in the number of patients with negative self-perceptions seeking cosmetic consultations, a new survey shows. In a survey of more than 100 board-certified d
- With Nods from Shape, InStyle and More, BTL Devices Sweep Magazine Award Seasonhttps://modernaesthetics.com/news/btl-devices-sweep-magazine-awards-season/2473085/BTL Aesthetics’ took home five awards from several aesthetic publications for Emsculpt Classic, Emsculpt NEO, and Emsella. Emsculpt therapy was named the winner of the 2020 Aestheticians Choice Award for Favorite Body Sculpting Device in Dermascop
- It's A Deal: Eirion Therapeutics, Shanghai Haohai Biological Technology Close $40M Series A Investment and Licensing Dealhttps://modernaesthetics.com/news/its-a-deal-eirion-therapeutics-inc-shanghai-haohai-biological-technology-closes-40m-series-a-investment-and-licensing-deal/2473070/Eirion Therapeutics, Inc. closed a $40 million Series A investment and licensing deal with Shanghai Haohai Biological Technology Ltd. The deal will result in a $32 million Series A Preferred Stock investment into Eirion along with exclusive licenses that will be for all of Eir
- FDA Greenlights Galderma's Restylane Defyne for Chin Augmentationhttps://modernaesthetics.com/news/fda-greenlights-galdermas-restylane-defyne-for-chin-augmentation/2473055/The U.S. Food and Drug Administration (FDA) has approved Restylane Defyne for the augmentation and correction of mild to moderate chin retrusion in adults over the age of 21. Restylane Defyne is a hyaluronic acid (HA) dermal filler that was first approved in 201
- Revance: ePosters Showcase Data for DaxibotulinumtoxinA and RHA Line at Maui Dermhttps://modernaesthetics.com/news/revance-eposters-showcase-data-for-daxibotulinumtoxina-and-rha-line-at-maui-derm/2473053/Three ePosters presented at the Maui Derm for Dermatologists 2021 meeting feature data for DaxibotulinumtoxinA for Injection and the RHA® Collection of hyaluronic acid based dermal fillers, both from Revance Therapeutics. Revance repo